NervGen Pharma nervgenpharma.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

NervGen Pharma creates solutions for the treatment of nerve damage. NervGen's core technology focuses on the protein tyrosine phosphatase sigma (PTPσ), a key neural receptor that inhibits nerve regeneration resulting in a loss of function in patients with spinal cord injury and other medical conditions. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for various medical conditions. A series of receptor ...Show all

NervGen Pharma creates solutions for the treatment of nerve damage. NervGen's core technology focuses on the protein tyrosine phosphatase sigma (PTPσ), a key neural receptor that inhibits nerve regeneration resulting in a loss of function in patient...Show all

Company (IPO / Went public)

Phone: 778-888-4101

Fax:

Suite 1703, Three Bentall Centre
595 Burrard Street
Vancouver, V7X 1J1
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NervGen Pharma $0.1M Mar 15, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NervGen Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)